Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
World Journal of Surgical Oncology|December 20, 2022
Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcomaMingkun Zhao, Minzhi Lv, Yuan Fang, et al.
World Journal of Surgical Oncology|May 18, 2022
Unplanned reoperation after resection of retroperitoneal sarcoma: experience based on a high-volume sarcoma centerAobo Zhuang, Mingkun Zhao, Yuan Fang, et al.
BMC Surgery|February 23, 2023
Development and validation of a nomogram for predicting morbidity in surgically resected primary retroperitoneal sarcomaAobo Zhuang, Yangju Chen, Lijie Ma, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 1, 2026
Phenotypic transition in retroperitoneal liposarcoma: Bridging well-differentiated and dedifferentiated subtypes through genomics, epigenetics, and the tumor microenvironmentAobo Zhuang, Xueling Wang, Yingxue Cheng, et al.
Journal of Clinical and Translational Research|January 23, 2023
Tumor grade and symptoms at presentation are survival risk factors in Chinese patients with primary retroperitoneal sarcomaAobo Zhuang, Yuan Fang, Michal Heger, et al.
Frontiers in Oncology|November 23, 2020
Small Nuclear Ribonucleoprotein Polypeptide N Accelerates Malignant Progression and Poor Prognosis in Colorectal Cancer Transcriptionally Regulated by E2F8Meiling Ji, Li Ren, Yang Lv, et al.
BMC Surgery|November 26, 2022
Which style of duodenojejunostomy is better after resection of distal duodenumWenshuai Liu, Jiongyuan Wang, Lijie Ma, et al.
Discover Oncology|November 1, 2023
Nomogram development and external validation for predicting overall survival and cancer-specific survival in patients with primary retroperitoneal sarcoma: a retrospective cohort studyJialiang Zheng, Aobo Zhuang, Xiaogang Xia, et al.
Life Sciences|June 5, 2023
Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapyJialiang Zheng, Fenglin Miao, Zhao Wang, et al.
Annals of Surgical Oncology|March 18, 2022
Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive CasesWentao Tang, Yu Liu, Meiling Ji, et al.
Pageof 3